BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soulele K, Macheras P, Karalis V. On the pharmacokinetics of two inhaled budesonide/formoterol combinations in asthma patients using modeling approaches. Pulm Pharmacol Ther 2018;48:168-78. [PMID: 29223508 DOI: 10.1016/j.pupt.2017.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Monou PK, Andriotis EG, Bouropoulos N, Panteris E, Akrivou M, Vizirianakis IS, Ahmad Z, Fatouros DG. Engineered mucoadhesive microparticles of formoterol/budesonide for pulmonary administration. Eur J Pharm Sci 2021;165:105955. [PMID: 34298141 DOI: 10.1016/j.ejps.2021.105955] [Reference Citation Analysis]
2 Ruzycki CA, Murphy B, Nathoo H, Finlay WH, Martin AR. Combined in Vitro-in Silico Approach to Predict Deposition and Pharmacokinetics of Budesonide Dry Powder Inhalers. Pharm Res 2020;37:209. [PMID: 32995953 DOI: 10.1007/s11095-020-02924-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Back HM, Lee JB, Kim A, Park SJ, Kim J, Chae JW, Sheen SS, Kagan L, Park HS, Ye YM, Yun HY. Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients. Pharmaceutics 2020;12:E336. [PMID: 32283726 DOI: 10.3390/pharmaceutics12040336] [Reference Citation Analysis]
4 Hu C, Miao J, Shu S, Wang Y, Zhu X, Luo Z. Pharmacokinetics, pharmacodynamics and safety of a novel extrafine BDP/FF/GB combination delivered via metered-dose inhaler in healthy Chinese subjects. Eur J Pharm Sci 2020;144:105198. [PMID: 31862312 DOI: 10.1016/j.ejps.2019.105198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]